InvestorsHub Logo

Trenddetector

08/27/20 12:15 PM

#111697 RE: B52T38 #111693

Thanks B52

C-20

08/27/20 1:47 PM

#111735 RE: B52T38 #111693

Great post a lot of insight and information. I’m not sure how exactly they conclude what is significant enough to gain EUA . In simple terms if the patients in phase 3 treated with Leronlimab have a 75% survival rate after 28days in your opinion is that enough to receive EUA